Real-World Outcomes Among Patients with Cystic Fibrosis Treated with Ivacaftor: 2012–2016 Experience
Crossref DOI link: https://doi.org/10.1007/s41030-020-00115-8
Published Online: 2020-04-18
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Higgins, Mark
Volkova, Nataliya
Moy, Kristin
Marshall, Bruce C.
Bilton, Diana
Funding for this research was provided by:
Vertex Pharmaceuticals
Text and Data Mining valid from 2020-04-18
Version of Record valid from 2020-04-18
Article History
Received: 28 February 2020
First Online: 18 April 2020